Jazz Pharmaceuticals Plc (JAZZ)

Jan 21, 2025

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Perpetual Ltd - MarketBeat

Jan 21, 2025

Jan 21, 2025

45,463 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Bought by Lmcg Investments LLC - MarketBeat

Jan 21, 2025

Jan 21, 2025

MassMutual Private Wealth & Trust FSB Acquires 17,681 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 21, 2025

Jan 21, 2025

2,442 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by Aaron Wealth Advisors LLC - MarketBeat

Jan 21, 2025

Jan 21, 2025

5,811 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Bought by Arkadios Wealth Advisors - MarketBeat

Jan 21, 2025

Jan 19, 2025

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Short Interest Update - MarketBeat

Jan 19, 2025

Jan 19, 2025

Kera Capital Partners Inc. Invests $288,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 19, 2025

Jan 18, 2025

Wedge Capital Management L L P NC Sells 48,679 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 18, 2025

Jan 17, 2025

Empirical Asset Management LLC Invests $5.36 Million in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 17, 2025

Jan 16, 2025

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Acquired by Hennion & Walsh Asset Management Inc. - MarketBeat

Jan 16, 2025

Jan 16, 2025

Burney Co. Grows Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 16, 2025

Jan 15, 2025

JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline - MSN

Jan 15, 2025

Jan 15, 2025

14 Best 52-Week High Stocks To Buy According to Analysts - Insider Monkey

Jan 15, 2025

Jan 15, 2025

JAZZ (Jazz Pharmaceuticals) Growth Rank : 7 (As of Jan. 15, 2025) - GuruFocus.com

Jan 15, 2025

Jan 15, 2025

Jazz Pharmaceuticals plc (JAZZ): Analysts Recommend This 52-Week High Stocks Now - Insider Monkey

Jan 15, 2025

Jan 14, 2025

Serina Therapeutics Appoints Former Jazz Pharmaceuticals Finance Executive Karen Wilson to Board - StockTitan

Jan 14, 2025

Jan 13, 2025

Acute Lymphocytic Leukemia Pipeline Analysis 2024: FDA - openPR

Jan 13, 2025

Jan 12, 2025

With EPS Growth And More, Jazz Pharmaceuticals (NASDAQ:JAZZ) Makes An Interesting Case - Simply Wall St

Jan 12, 2025

Jan 06, 2025

Jazz Pharmaceuticals CEO sells shares worth $185,145 By Investing.com - Investing.com Nigeria

Jan 06, 2025

Jan 06, 2025

Insider Selling: Jazz Pharmaceuticals plc (NASDAQ:JAZZ) CEO Sells 1,500 Shares of Stock - MarketBeat

Jan 06, 2025

Jan 06, 2025

Jazz Pharmaceuticals CEO sells shares worth $185,145 - Investing.com India

Jan 06, 2025

Jan 03, 2025

Centre Asset Management LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 03, 2025

Jan 03, 2025

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives $177.00 Consensus Target Price from Analysts - MarketBeat

Jan 03, 2025

Jan 01, 2025

JPMorgan Chase & Co. Lowers Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 01, 2025

Dec 28, 2024

Principal Financial Group Inc. Sells 66,821 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Dec 28, 2024

Dec 25, 2024

Sentiment Still Eluding Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - Simply Wall St

Dec 25, 2024

Dec 23, 2024

Jazz Pharmaceuticals: Should Sing A Better Tune In 2025 (NASDAQ:JAZZ) - Seeking Alpha

Dec 23, 2024

Dec 23, 2024

Drug Resistant Epilepsy Market Growth, Trends & Key Players - openPR

Dec 23, 2024

Dec 22, 2024

Barclays PLC Has $4.37 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Dec 22, 2024

Dec 21, 2024

Sanctuary Advisors LLC Acquires 9,804 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Dec 21, 2024

Dec 18, 2024

Akari Therapeutics Names Interim CEO Patel as Permanent Chief, Adds Jazz Pharma Veteran to Board - StockTitan

Dec 18, 2024

Dec 18, 2024

Jazz Pharmaceuticals CEO to retire by end 2025, search begins - Investing.com Australia

Dec 18, 2024

Dec 18, 2024

Public Employees Retirement System of Ohio Makes New $2.49 Million Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Dec 18, 2024

Dec 17, 2024

Jazz Pharmaceuticals CEO to Present Strategic Vision at JP Morgan Healthcare Conference 2025 - StockTitan

Dec 17, 2024

Dec 17, 2024

Big Peninsula drugmaker on the hunt for new CEO - The Business Journals

Dec 17, 2024

Dec 17, 2024

Jazz Pharmaceuticals CEO to Retire, Succession Search Underway - Sleep Review

Dec 17, 2024

Dec 17, 2024

Graft-Versus-Host Disease Market on Track for Major Expansion - openPR

Dec 17, 2024

Dec 17, 2024

Jazz Pharmaceuticals Announces CEO Succession Plan - PharmiWeb.com

Dec 17, 2024

Dec 17, 2024

Bruce Cozadd to retire as Jazz’s CEO - BioCentury

Dec 17, 2024

Dec 17, 2024

Jazz Pharmaceuticals CEO to retire - MSN

Dec 17, 2024

Dec 16, 2024

Bruce Cozadd to Retire as Chief Executive Officer of Jazz Pharmaceuticals plc Upon Appointment of Successor by the End of 2025 - Marketscreener.com

Dec 16, 2024

Dec 16, 2024

Jazz Pharmaceuticals CEO to retire by end of 2025 - Investing.com South Africa

Dec 16, 2024

Dec 16, 2024

Jazz to search for new chief as CEO plans retirement - BioPharma Dive

Dec 16, 2024

Dec 16, 2024

Jazz Pharmaceuticals CEO to Step Down After Two Decades of Transformative Leadership - StockTitan

Dec 16, 2024

Dec 16, 2024

Franklin Resources Inc. Acquires 48,708 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Dec 16, 2024

Dec 16, 2024

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Teachers Retirement System of The State of Kentucky - MarketBeat

Dec 16, 2024

Dec 14, 2024

Is Now The Time To Put Jazz Pharmaceuticals (NASDAQ:JAZZ) On Your Watchlist? - Yahoo Finance

Dec 14, 2024

Dec 13, 2024

Jazz upgraded to Overweight at Morgan Stanley after Ziihera launch - Yahoo Finance

Dec 13, 2024

Dec 13, 2024

Morgan Stanley boosts Jazz Pharmaceuticals stock rating, sees upside with Ziihera launch - Investing.com Nigeria

Dec 13, 2024

Dec 12, 2024

Jazz Pharmaceuticals retains stock target, Overweight rating on FDA approval By Investing.com - Investing.com Nigeria

Dec 12, 2024